Presentation on theme: "Clinical Laboratory Improvement Amendments of 1988 ( CLIA ’ 88 )"— Presentation transcript:
1Clinical Laboratory Improvement Amendments of 1988 ( CLIA ’ 88 ) Federal regulations which govern test results that are used to assess a patient’s condition or make a clinical decision about the patientCLIA’ 88 classifies tests depending upon complexity as: high, moderate, provider-performed microscopy, or waivedA CLIA Certificate of Waiver is required for labs performing only waived testing
2Waived TestsWaived tests include test systems cleared by the FDA for home use and those tests approved for waiver under CLIA criteria. CLIA requires that waived tests must be simple and have a low risk for erroneous results. This does not mean that waived tests are completely error-proof. They should be performed correctly
3Testing OversightCLIA does not specify requirements for directors of laboratories with a Certificate of Waiver ( some states require a physician )The person whose name appears on the CLIA Certificate as the Medical Director is responsible for testing oversight and decision making .
4Medical Director or Designee Responsibilities Ensure appropriate preparation prior to testing, i.e. patient ID, collection and handlingIdentify staff responsible for performing and supervising testing.Ensure staff are trained in each test they perform, aspects of safety, and QC prior to reporting test resultsEnsure periodic evaluation of competencyEspecially important since no specific degree or certification is required and turnover rates are high
5Medical Director or Designee Responsibilities:Establish written policies and procedures for waived testingMake decisions on how the test results are used and when follow up testing is requiredApprove policies before a test is put in placeReview and approve policies every 3 years or more often if changes are made
6Importance of Getting it Right! Consider this:Waived tests are used to adjust medication doses, i.e. anticoagulant therapyPregnancy test prior to undergoing radiology testsGlucose monitoring in diabetic patients
7Importance of Preanalytical Processes Preanalytical errors are the main cause of laboratory errorsWhy?Human factorDifficult to detect and correct
8Focus on Prevention!Standardize processes & understand variables, i.e.:Two patient identifiersUse dedicated staff for collectionCorrect order of drawMethods to prevent hemolysis
9Two Patient Identifiers Two patient identifiers are used when collecting blood or other samples for clinical testingTwo patient identifiers are used when providing other treatments or proceduresThe patient’s physical location is not used as an identifier Containers used for blood and other specimens are labeled in the presence of the patientRef: Joint Commission, camlab,2007
10Methods to prevent hemolysis Appropriate needle boreRemove the tourniquet as soon as possibleAllow alcohol to dryAvoid vigorous mixing or shakingAvoid prolonged contact of serum or plasmawith cells
11Staff Training and Periodic Competencies Staff identified by name or job descriptionStaff trained for each test they are authorized to perform including performance of quality controlStaff trained on the use of each instrument operation, calibration and maintenance
12Waived Policy Highlights Waivered laboratory procedures (as defined by the Clinical Laboratory Improvement Amendment of 1988) may be performed by certified personnel with the guidance and assistance of the Medical Director of the lab or designee or may be performed by RMAs, CMAs, Certified Phlebotomists who have been authorized to perform the tests
14Assessing Competencies Competency assessed using at least two ofthe following:Direct observation of testing/or submit a blind specimenReview of result reporting, track errorsReview of maintenance and QC logsUse of a written examCompetency should be assessed at leastat orientation and annually thereafter
15Components of Policies and Procedures for Waived Testing Confirmatory testing and result follow-upSpecimen type, collection, ID, and labelingSpecimen preservationInstrument maintenance and function checks ( calibration )Storage of reagents
16Components, continued: Reagent use, expiration datesQuality control frequency and type ( including corrective action when unacceptable )Test performanceReporting results ( do not report if quality control is unacceptable )Equipment validation
17Waived Policy Highlights PROCEDURES:A Bedside Glucose Accu-Chek AdvantagePURPOSE: This policy establishes guidelines for the performance of accurate bedside glucose testing used in clinical decision making such as the rapid evaluation of patients with suspected hypo-or hyperglycemia, the determination of appropriate insulin doses or infusion rates, and assessing the effectiveness of treatment regimens. This method is not used for the diagnosis of diabetes mellitus. These guidelines follow recommendations defined by certain regulatory agencies as dictated by principles of good laboratory practice.
18Waived Policy Highlights Negative Result: Only one (1) pink colored line appears in the control region. No apparent pink colored line is visible in the test region. A negative result indicated that there is no Strep A antigen in the swab sample or the Strep A antigen concentration is below the detection level. A negative result should be cultured to confirm the absence of Strep A infection.
19Waived Policy Highlights/Result Follow up Critical Values and Unusual Results:Any glucose value <40 mg/dL or >400 mg/dL should be repeated. Repeat results exceeding these limits are designated as Critical Values and should be reported as soon as practical to the physician or physician extenderIf at any time results of bedside glucose testing, regardless of whether they are critical values, are inconsistent with the patient’s status, notify the physician or physician extender for instructions.
20Quality ControlQuality Control checks are performed at the frequency and number of levels recommended by the manufacturerIf the manufacturer doesn’t recommend the frequency and number, the medical director, designee or organization must define
21Documentation of Quality Control Controls may be documented on a quality control log or located in the patient’s clinical recordOften internal quality controls are documented in the patient’s clinical record, while external is documented on a log along with reagent lot #s, open dates and expiration dates
22Waived Policy Highlights Quality Control:Accu-Chek Comfort Curve glucose controls, low and high levelsare used for quality control as follows:Frequency: Run both levels of controls (low and high) with thefirst run of the day. Also, both levels of controls should be run:Each time a new vial of test strips is opened.When a vial of test strips has been left opened.If the Advantage Meter has been dropped.Whenever the patient’s result contradicts the patient’s condition.When batteries are replaced.
23Waived Policy Highlights Validation of Controls:Log control results along with other required information on the Quality Control Log. If control test results are not within expected limits, the following steps are recommended:Confirm that the HemoCue Microcuvettes are within the expiration date shown on the label.Retest with new controls.Log the invalid control results and the repeat resultson the Quality Control Log along with the corrective action used.Special Note: If these steps do not correct the problem, call Northern Hospital Laboratory for assistance or contact HemoCue Technical Services by callingDO NOT REPORT PATIENT TEST RESULTS!
24Instrument Maintenance/Calibration Follow manufacturer’s instructions for instrument maintenance and calibration checksInstrument maintenance and calibration checks must be documentedVery important! Individual test results can be associated with quality control, reagent lots, instrument records, and calibration checks
25Preventive Maintenance Schedule C. HemoCue 201+-Hemoglobin System1. Daily a. Remove the cuvette holder from the photometer. Clean the cuvette holder with 70% alcohol or mild soap solution. Completely dry the cuvette holder before replacing in the photometer. Wipe the surfaces with a commercially pre moistened disinfecting cloth ( must be EPA registered disinfectant ) SQUEEZING OFF THE EXCESS SOLUTION.2. Monthly a. Monthly inspection of workstation by designee.3. Annually a. Have NHSC Biomedical Engineering check for proper electrical grounding.REFERENCE: 1. HemoCue 201+ Blood Hemoglobin Operating Manual
26Result ReportingQuantitative test result reports in the patient’s clinical record for waived testing are accompanied by reference limits ( normal values ) specific to the test method used and the population servedReference: Joint Commission Standards for Waived Testing
27Hard Copy or EMRResult on a hard copy: Design the lab result form with reference limits adjacent to the test resultResult in EMR: EMR page for entering lab results may not be formatted to have reference limits adjacent to the test resultIf not what? The reference limits must be located elsewhere in the medical record and the result must have a notation directing the reader to that location
28Documentation of Critical Values Very Important to document reporting of critical values, i. e.,Critical value reported to Dr. John Smith at 2:30 pm on April 15, 2012 by Mary Midkiff
29Morbidity and Mortality Weekly Report Indicates Risks Lack of current manufacturers’ instructions including updatesFailure to follow manufacturers’ instructions including performing quality controlReporting of incorrect resultsLack of adherence to expiration datesInappropriate storage requirementsReference: Morbidity and Mortality Weekly report, November 11, 2005
30Morbidity and Mortality , conti., Failure to perform test system function checks or calibration checksLack of documentation, including quality control and tests performedInadequate trainingLack of understanding about good laboratory practicesReference: Morbidity and Mortality Weekly Report, November 11,2005